(Q37787612)

23 August 2017

title

Antibiotic hypersensitivity in CF: drug-induced life-threatening hemolytic anemia in a pediatric patient (English)

1 reference

23 August 2017

Antibiotic hypersensitivity in CF: Drug-induced life-threatening hemolytic anemia in a pediatric patient (English)

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

11 July 2024

1 reference

1 reference

Alma Chavez

1

1 reference

23 August 2017

Amir Mian

2

1 reference

23 August 2017

Douglas Blackall

4

1 reference

23 August 2017

Gulnur Com

5

1 reference

23 August 2017

Amy M. Scurlock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833594

11 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20833594

11 July 2024

publication date

15 September 2010

1 reference

full work available at URL

23 August 2017

http://www.cysticfibrosisjournal.com/article/S1569199310001098/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833594

https://api.elsevier.com/content/article/PII:S1569199310001098?httpAccept=text/xml

11 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

https://api.elsevier.com/content/article/PII:S1569199310001098?httpAccept=text/plain

11 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Journal of Cystic Fibrosis

11 July 2024

published in

1 reference

23 August 2017

volume

9

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

433-438

1 reference

Clinical practice. Antibiotic allergy

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Skin reactions to antibacterial agents in general practice

11 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Antibiotic hypersensitivity reactions in cystic fibrosis

11 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Beta-lactam allergy in adults with cystic fibrosis.

11 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses

11 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Drug-induced immune hemolytic anemia

11 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Piperacillin-induced immune hemolysis: new cases and a concise review of the literature

11 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm

11 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Adverse drug reactions: types and treatment options

11 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Immune mechanism of drug hypersensitivity.

11 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Antibiotic hypersensitivity in patients with CF.

11 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

The changing spectrum of drug-induced immune hemolytic anemia

11 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis

11 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment--a retrospective analysis in 38 children with cystic fibrosis

11 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis

11 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Adverse reactions to piperacillin in adults with cystic fibrosis.

11 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics

11 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Haemolytic anaemia following treatment with piperacillin in a patient with cystic fibrosis

11 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method

11 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity

11 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

Beta-lactam antibiotics inhibit human in vitro granulopoiesis and proliferation of some other cell types

11 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JCF.2010.08.010

11 July 2024

Identifiers

1 reference

23 August 2017

1 reference